CTLA4 and triple-negative breast carcinoma: Curcumin is a natural product that can reduce tumor cell PDL1 content by promoting its ubiquitination and can improve in vivo anti-CTLA-4 immunotherapy efficacy in murine 4T1 triple-negative breast cancer [27].